|
Cancer Center Support Grant
|
2P30CA033572-35
|
$2,543,187
|
$76,296
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S3
|
$865,000
|
$25,950
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-35S1
|
$43,750
|
$1,313
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Combined breast MRI/biomarker strategies to identify aggressive biology
|
3U01CA189283-04S1
|
$190,203
|
$190,203
|
SEEWALDT, VICTORIA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Combined breast MRI/biomarker strategies to identify aggressive biology
|
5U01CA189283-04
|
$663,841
|
$663,841
|
SEEWALDT, VICTORIA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
DF/HCC Kidney Cancer SPORE
|
5P50CA101942-14
|
$2,300,000
|
$69,000
|
MCDERMOTT, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Supine Breast MRI Standardization for Breast Cancer Locator
|
1R44CA232862-01
|
$221,343
|
$221,343
|
KRISHNASWAMY, VENKATARAMANAN
|
CAIRNSURGICAL, INC.
|
|
Breast Cancer Locator
|
5R44CA210810-04
|
$969,868
|
$969,868
|
KRISHNASWAMY, VENKATARAMANAN
|
CAIRNSURGICAL, INC.
|
|
Radiogenomic tools for prediction of breast cancer neo-adjuvant chemotherapy response from pre-treatment MRI
|
1F31CA221383-01A1
|
$42,074
|
$42,074
|
BRAMAN, NATHANIEL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
2P30CA043703-28
|
$5,637,954
|
$451,036
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-28S1
|
$249,965
|
$19,997
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Contribution of Gynecologic and Breast Cancer Biospecimens from African American women to HCMI
|
3P30CA043703-28S2
|
$48,000
|
$3,840
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
MR Fingerprinting and Computerized Decision Support for Prostate Cancer
|
5R01CA208236-02
|
$636,773
|
$636,773
|
GULANI, VIKAS
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Image-guided EMT inhibition for treating metastatic breast cancer
|
5R01CA194518-04
|
$473,853
|
$473,853
|
LU, ZHENG-RONG
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Targeted MRI contrast agents for differential diagnosis of prostate cancer
|
5R01CA211762-02
|
$424,315
|
$424,315
|
LU, ZHENG-RONG
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Diagnosis and longitudinal monitoring of metastatic prostate cancer through molecular MR imaging
|
5R01CA202814-03
|
$394,519
|
$394,519
|
STEINMETZ, NICOLE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Bladder Fiducial Markers and Diffusion-MRI to Optimize Bladder Chemo-Radiotherapy
|
5R01CA201709-03
|
$724,638
|
$724,638
|
GARCIA, MAURICE
|
CEDARS-SINAI MEDICAL CENTER
|
|
Glial tumor image-guided surgery and treatment
|
5R01CA209921-03
|
$519,467
|
$171,424
|
HOLLER, EGGEHARD
|
CEDARS-SINAI MEDICAL CENTER
|
|
High resolution volumetric MRI for prostate cancer active surveillance
|
5R01CA217098-02
|
$379,039
|
$379,039
|
KIM, HYUNG
|
CEDARS-SINAI MEDICAL CENTER
|
|
Differential MRI imaging for brain tumor metastases diagnosis and treatment monitoring
|
5R01CA188743-04
|
$497,850
|
$497,850
|
LJUBIMOVA, JULIA
|
CEDARS-SINAI MEDICAL CENTER
|
|
FrostBite - A Unique Catheter for Endoscopic Cryoablation
|
5R44CA183265-03
|
$737,450
|
$221,235
|
BAUST, J
|
CELL PRESERVATION SERVICES, INC.
|
|
Chemically produced neural progenitors loaded with ferumoxide-protamine sulfate complex for visualization of gliomas
|
1R43CA228726-01A1
|
$300,000
|
$300,000
|
ALEXANIAN, ARSHAK
|
CELL REPROGRAMMING AND THERAPEUTICS, LLC
|
|
Tablet-Based Augmented Reality for Fast CT Guidance with Reduced Radiation
|
1R43CA228865-01
|
$224,529
|
$224,529
|
FOROUGHI, PEZHMAN
|
CLEAR GUIDE MEDICAL, INC.
|
|
Molecular MR Imaging of the Desmoplastic Response in Pancreatic Cancer
|
3R44CA200186-03S1
|
$209,717
|
$209,717
|
HUMBLET, VALERIE
|
COLLAGEN MEDICAL, LLC
|
|
AutoRegister: A system for enhancing the accuracy of tumor change detection
|
5R42CA183150-03
|
$750,000
|
$750,000
|
WIGHTON, PAUL
|
CORTICOMETRICS, LLC
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S1
|
$445,796
|
$13,374
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S2
|
$59,495
|
$1,785
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S3
|
$62,500
|
$1,875
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S4
|
$149,528
|
$4,486
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S5
|
$60,691
|
$1,821
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S6
|
$228,108
|
$6,843
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S7
|
$199,806
|
$5,994
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
5P30CA006516-53
|
$11,504,298
|
$345,129
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
MRI fluorescence tomography for quantifying tumor receptor concentration in vivo
|
5R01CA184354-05
|
$519,501
|
$519,501
|
DAVIS, SCOTT
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-39S1
|
$100,606
|
$5,030
|
LEACH, STEVEN
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-39S2
|
$127,198
|
$6,360
|
LEACH, STEVEN
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-39S3
|
$112,196
|
$5,610
|
LEACH, STEVEN
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-39S4
|
$67,481
|
$3,374
|
LEACH, STEVEN
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-39S5
|
$35,000
|
$1,750
|
LEACH, STEVEN
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
5P30CA023108-39
|
$3,139,824
|
$156,991
|
LEACH, STEVEN
|
DARTMOUTH COLLEGE
|
|
Toward a screening designation for SoftVue: A multi-center clinical trial in support of Pre-Market Approval.
|
5R44CA165320-06
|
$857,782
|
$428,891
|
DURIC, NEBOJSA
|
DELPHINUS MEDICAL TECHNOLOGIES, INC.
|
|
The Duke Preclinical Research Resources for Quantitative Imaging Biomarkers
|
5U24CA220245-02
|
$631,958
|
$631,958
|
BADEA, CRISTIAN
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA014236-44S1
|
$59,375
|
$2,969
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA014236-44S2
|
$249,377
|
$12,469
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA014236-44S3
|
$84,682
|
$4,234
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA014236-44S4
|
$119,106
|
$5,955
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA014236-44
|
$5,679,062
|
$283,953
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Image guided targeted biopsy of clinically significant prostate cancer with acoustic radiation force
|
5R01CA142824-07
|
$536,651
|
$536,651
|
NIGHTINGALE, KATHRYN
|
DUKE UNIVERSITY
|
|
EMPOWER Study: Promoting BC Screening in Women Who Survived Childhood Cancer
|
2R01CA134722-06A1
|
$940,195
|
$940,195
|
OEFFINGER, KEVIN
|
DUKE UNIVERSITY
|
|
Experimental Therapy for Brain Tumors
|
1P01CA225622-01
|
$2,170,371
|
$217,037
|
SAMPSON, JOHN
|
DUKE UNIVERSITY
|
Total relevant funding to Nuclear Magnetic Resonance Imaging (NMR) for this search: $89,079,092
|